Stack L8
OpenEvidence
Recent Business Signals
Jul 20, 2026
news_mention
Medical AI Startup OpenEvidence Weighs $200 Million Funding Round - PYMNTS.com Medical AI Startup OpenEvidence Weighs $200 Million Funding Round PYMNTS.com
source: gnews-openevidence
Jul 20, 2026
news_mention
OpenEvidence Reportedly Seeks $200M Funding at $20B Valuation Amid Rapid AI Healthcare Growth - Digital Health News OpenEvidence Reportedly Seeks $200M Funding at $20B Valuation Amid Rapid AI Healthcare Growth Digital Health News
source: gnews-openevidence
Jul 18, 2026
news_mention
OpenEvidence reportedly eyes $200M raise at $20B valuation, signaling AI healthcare's breakneck growth - Crypto Briefing OpenEvidence reportedly eyes $200M raise at $20B valuation, signaling AI healthcare's breakneck growth Crypto Briefing
source: gnews-openevidence
Funding & valuation history
Jan 1, 2026 · funding-research
OpenEvidence raised $250M Series D led by Thrive Capital and DST Global at a $12B valuation, with participation from Sequoia, Nvidia, Kleiner Perkins, Blackstone, BOND, Craft Ventures, and Mayo Clinic.
Jan 1, 2026 · funding-research
OpenEvidence closed a $250M Series D co-led by Thrive Capital and DST Global at a $12B valuation.
Jan 1, 2026 · funding-research
OpenEvidence acquired Amaro, a GV-backed AI startup focused on advertising infrastructure and automation, to strengthen its ad-monetization engine.
Jan 1, 2026 · funding-research
OpenEvidence raised a $250 million Series D at a $12 billion valuation, co-led by Thrive Capital and DST Global.
Oct 1, 2025 · funding-research
OpenEvidence raised $200M Series C led by GV (Google Ventures) at a $6.1B valuation, with participation from Sequoia, Kleiner Perkins, Blackstone, Thrive, Coatue, BOND, and Craft.
Oct 1, 2025 · funding-research
OpenEvidence raised a $200 million Series C at a $6.1 billion valuation, led by GV with participation from Sequoia Capital, Kleiner Perkins, Blackstone, Thrive Capital, Coatue, BOND, and Craft Ventures.
Oct 1, 2025 · funding-research
OpenEvidence closed a $200M Series C led by GV with participation from Sequoia, Kleiner Perkins, Blackstone, Thrive, Coatue, BOND, and Craft at a $6.1B valuation.
Jul 1, 2025 · funding-research
OpenEvidence raised a $210 million Series B at a $3.5 billion valuation, co-led by GV and Kleiner Perkins.
Jul 1, 2025 · funding-research
OpenEvidence closed a $210M Series B co-led by GV and Kleiner Perkins with participation from Sequoia, Coatue, Conviction, and Thrive at a $3.5B valuation.
Jul 1, 2025 · funding-research
OpenEvidence raised $210M Series B led by GV and Kleiner Perkins at a $3.5B valuation, with participation from Sequoia, Coatue, Conviction, and Thrive Capital.
Recent Hiring (60 days)
No specialty signals in the last 60 days.